Literature DB >> 10456887

Sulfated polysaccharide-directed recruitment of mammalian host proteins: a novel strategy in microbial pathogenesis.

T D Duensing1, J S Wing, J P van Putten.   

Abstract

Fundamental to the virulence of microbial pathogens is their capacity for adaptation and survival within variable, and often hostile, environments encountered in the host. We describe a novel, extragenomic mechanism of surface modulation which may amplify the adaptive and pathogenic potential of numerous bacterial species, including Staphylococcus, Yersinia, and pathogenic Neisseria species, as well as Helicobacter pylori and Streptococcus pyogenes. The mechanism involves specific bacterial recruitment of heparin, glycosaminoglycans, or related sulfated polysaccharides, which in turn serve as universal binding sites for a diverse array of mammalian heparin binding proteins, including adhesive glycoproteins (vitronectin and fibronectin), inflammatory (MCP-3, PF-4, and MIP-1alpha) and immunomodulatory (gamma interferon) intermediates, and fibroblast growth factor. This strategy impacts key aspects of microbial pathogenicity as exemplified by increased bacterial invasion of epithelial cells and inhibition of chemokine-induced chemotaxis. Our findings illustrate a previously unrecognized form of parasitism that complements classical virulence strategies encoded within the microbial genome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456887      PMCID: PMC96765     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Molecular modeling of protein-glycosaminoglycan interactions.

Authors:  A D Cardin; H J Weintraub
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb

2.  Novel purification of vitronectin from human plasma by heparin affinity chromatography.

Authors:  T Yatohgo; M Izumi; H Kashiwagi; M Hayashi
Journal:  Cell Struct Funct       Date:  1988-08       Impact factor: 2.212

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin.

Authors:  J Sudhalter; J Folkman; C M Svahn; K Bergendal; P A D'Amore
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

5.  Quantitation of spreading factor in human biologic fluids.

Authors:  M C Shaffer; T P Foley; D W Barnes
Journal:  J Lab Clin Med       Date:  1984-05

6.  Heparin-binding properties of human serum spreading factor.

Authors:  D W Barnes; J E Reing; B Amos
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

7.  Activation of vitronectin (serum spreading factor) binding of heparin by denaturing agents.

Authors:  M Hayashi; T Akama; I Kono; H Kashiwagi
Journal:  J Biochem       Date:  1985-10       Impact factor: 3.387

8.  Serum spreading factor (vitronectin) is present at the cell surface and in tissues.

Authors:  E G Hayman; M D Pierschbacher; Y Ohgren; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element.

Authors:  S Hammerschmidt; R Hilse; J P van Putten; R Gerardy-Schahn; A Unkmeir; M Frosch
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

10.  Mediation of adherence of streptococci to human endothelial cells by complement S protein (vitronectin).

Authors:  P Valentin-Weigand; J Grulich-Henn; G S Chhatwal; G Müller-Berghaus; H Blobel; K T Preissner
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

View more
  35 in total

1.  Bartonella henselae Pap31, an extracellular matrix adhesin, binds the fibronectin repeat III13 module.

Authors:  S M Dabo; A W Confer; B E Anderson; Snehalata Gupta
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium.

Authors:  Donavon J Hess; Michelle J Henry-Stanley; Stanley L Erlandsen; Carol L Wells
Journal:  Med Microbiol Immunol       Date:  2005-12-24       Impact factor: 3.402

3.  Two domains within the Mycoplasma hyopneumoniae cilium adhesin bind heparin.

Authors:  Cheryl Jenkins; Jody L Wilton; F Chris Minion; Linda Falconer; Mark J Walker; Steven P Djordjevic
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Mhp107 is a member of the multifunctional adhesin family of Mycoplasma hyopneumoniae.

Authors:  Lisa M Seymour; Linda Falconer; Ania T Deutscher; F Chris Minion; Matthew P Padula; Nicholas E Dixon; Steven P Djordjevic; Mark J Walker
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

Review 5.  Anticoagulant modulation of inflammation in severe sepsis.

Authors:  Karen S Allen; Eva Sawheny; Gary T Kinasewitz
Journal:  World J Crit Care Med       Date:  2015-05-04

6.  Mycoplasma fermentans binds to and invades HeLa cells: involvement of plasminogen and urokinase.

Authors:  Amichai Yavlovich; Avigail Katzenell; Mark Tarshis; Abd A-R Higazi; Shlomo Rottem
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Mycoplasma gallisepticum invades chicken erythrocytes during infection.

Authors:  Gunther Vogl; Astrid Plaickner; Susan Szathmary; László Stipkovits; Renate Rosengarten; Michael P Szostak
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

8.  Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells.

Authors:  Claudia Sa E Cunha; Natalie J Griffiths; Mumtaz Virji
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

Review 9.  Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease.

Authors:  Darryl J Hill; Natalie J Griffiths; Elena Borodina; Mumtaz Virji
Journal:  Clin Sci (Lond)       Date:  2010-02-09       Impact factor: 6.124

10.  Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats.

Authors:  Jorrit J Hofstra; Alexander D Cornet; Bart F de Rooy; Alexander P Vlaar; Tom van der Poll; Marcel Levi; Sebastian Aj Zaat; Marcus J Schultz
Journal:  Crit Care       Date:  2009-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.